All products / DC2071
ABR-215062 (Laquinimod)
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $300 USDRequest a quote → |
| 250 mg | $600 USDRequest a quote → |
| 1 g | $1,000 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
Laquinimod is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC2071 |
|---|---|
| Product name | ABR-215062 (Laquinimod) |
| CAS | 248281-84-7 |
| Molecular formula | C19H17ClN2O3 |
| Molecular weight | 356.8029 |
| Purity | 99% |
| SMILES | ClC1=C([H])C([H])=C([H])C2=C1C(=C(C(N(C1C([H])=C([H])C([H])=C([H])C=1[H])C([H])([H])C([H])([H])[H])=O)C(N2C([H])([H])[H])=O)O[H] |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — ABR-215062 (Laquinimod) (DC2071)Source references
[1]. Schulze-Topphoff, Ulf., et al. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLoS One (2012), 7(3), e33797. [2]. Toubi E, et al. Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis. J Neuroimmunol. 2012 Oct 15;251(1-2):45-54. [3]. Brück W, et al. Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol. 2012 Sep;124(3):411-24.
